Hyperfine, Inc. (HYPR)
1.17
-0.04
(-3.31%)
USD |
NASDAQ |
Mar 20, 10:24
Hyperfine EPS Diluted (Quarterly) : -0.0628 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pulse Biosciences, Inc. | -0.2572 |
| Celldex Therapeutics, Inc. | -1.223 |
| Plus Therapeutics, Inc. | -0.0412 |
| Atossa Therapeutics, Inc. | -1.009 |
| Abeona Therapeutics, Inc. | -0.3717 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.912M |
| Revenue (Quarterly) | 5.293M |
| Total Expenses (Quarterly) | 11.20M |
| Enterprise Value | 81.85M |
| Gross Profit Margin (Quarterly) | 50.90% |
| Profit Margin (Quarterly) | -111.7% |
| Earnings Yield | -38.02% |
| Normalized Earnings Yield | -38.20 |